Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 3, 2003, Pages 1042-1047

  Funatsu, Hideharu ^a   Yamashita, Hidetoshi ^b   Noma, Hidetaka ^a,c   Mochizuki, Hideki ^c   Mimura, Tatsuya ^d   Ikeda, Tomohiro ^a,e   Hori, Sadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOSTATIN; GROWTH FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA NEOVASCULARIZATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VITREOUS BODY; VITREOUS SURGERY;

ADULT; AGED; BIOLOGICAL MARKERS; COLLAGEN; DIABETIC RETINOPATHY; ENDOSTATINS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LASER COAGULATION; LYMPHOKINES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITRECTOMY; VITREOUS BODY;

EID: 0037334780     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0374     Document Type: Article

References (20)

1. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143-156.
2. Hananan D, Foreman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
3. Funatsu H, Yamashita H, Noma H, Shimizu E, Yamashita T, Hori S. Stimulation and inhibition of angiogenesis in diabetic retinopathy. Jpn J Ophthalmol. 2001;45:577-584.
4. Noma H, Funatsu H, Yamashita H, Kitano S, Mishima H, Hori S. Regulation of angiogenesis in diabetic retinopathy: possible balance between stimulator and inhibitor. Arch Ophthalmol. 2002; 120:1075-1080.
5. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS Report Number 10. Ophthalmology. 1991;98(suppl): 786-806.
6. Early Treatment Diabetic Retinopathy Study Research Group: Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS Report Number 12. Ophthalmology. 1991; 98(suppl):823-833.
7. SAS Institute Inc. SAS/STAT Software. Changes and enhancements through release 8e. Cary, NC: SAS Institute, 1999.
8. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
9. Katsura Y, Okano T, Noritake M, et al. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care. 1998;21:1759-1763.
10. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
11. Halfter W, Dong S, Schurer B, Cole GJ. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem. 1998; 273:25404-25412.
12. Yamaguchi N, Anand-Apte B, Lee M, et al. Endostatin inhibits VEGF-induced enclothelial cell migration and tumor growth independently of zinc binding. EMBO J 1999;18:4414-4423.
13. Mori K, Ando A, Gehlbach P, et al. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing endostatin. Am J Pathol. 2001;159:313-320.
14. Spranger J, Hammes HP, Preissner KT, Schatz H, Pfeiffer AFH. Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation. Diabetologia. 2000;43:1404-1407.
15. Boulton M, Foreman D, Williams G, McLeod D. VEGF localization in diabetic retinopathy. Br J Ophthalmol. 1998;82:561-568.
16. Pournaras CJ, Tsacopoulos M, Strommer K, Gliodi N, Leuenberger PM. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology: 1990;97:1329-1333.
17. Pournaras CJ, Miller JW, Gragoudas ES, et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. Arch Ophthalmol. 1997;115:1553-1558.
18. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology. 1991;98(suppl):766-785.
19. Spranger J, Osterhoff M, Reimann M, et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes. 2001;50:2641-2645.
20. Ishida K, Yoshimura N, Yoshida M, Honda Y. Upregulation of transforming growth factor-β after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 1998;39:801-807.